Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710481019 | Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3710482014 | Isoniazid- and pyrazinamide- and rifampin-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3710483016 | Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | Product containing isoniazid and pyrazinamide and rifampicin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | Product containing isoniazid and rifampicin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Has active ingredient | Pyrazinamide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Has active ingredient | Rifampicin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Has active ingredient | Isoniazid | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | Product containing pyrazinamide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet | Is a | False | Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | True | Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | True | Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR